Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

ESRD (End-Stage Renal Disease) · Kidney Transplantation · Xenotransplantation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

New York University Langone Health, New York, New York, United States
Contact: Study coordinator (Karen Khalil) · karen.khalil@nyulangone.org · 347-514-2758
Contact: Principal Investigator (Robert A Montgomery, MD, DPhil)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

REgulatory T Cell Therapy to Achieve Immunosuppression REduction

Kidney Transplantation

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Chicago, United States

Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation

Kidney Disease, End-Stage · Kidney Transplant · Kidney

Abroad (travel likely)Recruiting

Gaziantep, Turkey (Türkiye)

Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates

Obesity, Morbid · End Stage Renal Disease · Kidney Transplantation

Abroad (travel likely)Recruiting

Rome, Italy

Comparative Study of Prognosis and QOL Between APD-RPM and CAPD

End-stage Renal Disease

Abroad (travel likely)Recruiting

Beijing, China